Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ALS LIMITED Major Shareholding Notification 2022

Jul 26, 2022

64365_rns_2022-07-26_2e234397-9b9e-43a8-932a-ae53d485cbfa.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Form 604

Corporations Act 2001 Section 671B

Notice of change of interests of substantial holder

To Company Name/Scheme HRL Holdings Ltd ( HRL ) ACN/ARSN ACN 120 896 371

1. Details of substantial holder (1)

Name Australian Laboratory Services Pty. Ltd. (ACN 009 936 029) and ALS Limited (ACN 009 657 489) Australian Laboratory Services Pty. Ltd. (ACN 009 936 029) and ALS Limited (ACN 009 657 489) Australian Laboratory Services Pty. Ltd. (ACN 009 936 029) and ALS Limited (ACN 009 657 489) Australian Laboratory Services Pty. Ltd. (ACN 009 936 029) and ALS Limited (ACN 009 657 489)
ACN/ARSN (if applicable) As above
There was a change in the interests of the
substantial holder on 26 / 07 / 2022
The previous notice was given to the company on21 / 07 / 2022
The previous notice was dated 21 / 07 / 2022
2. Previous and present voting power
The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an
relevant interest(3)in when last required,and when now required,togive a substantial holdingnotice to the companyor scheme,are as follows:
Class of securities (4)Previous notice Present notice
Person’s votesVoting power(5) Person’s votes Voting power
Fully paid ordinary shares in HRL417,964,24084.23% 425,884,273 85.83%
3. Changes in relevant interests
Particulars of each change in, or change in the nature of, a relevant interest of the substantial holder or an associate in voting securities of the
scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows:
Date of change Person whoseNature of change (6) Consideration Class and number of Person’s votes
relevant interest given in relation securities affected affected
changed to change (7)
26 / 07 / 2022 Australian LaboratoryAcquisition of fully $1,267,205.28 7,920,033 fully paid 7,920,033
Services Pty. Ltd.paid ordinary shares (being $0.16 per ordinary shares in
(ACN 009 936 029)in HRL by Australian fully paid ordinary HRL
Laboratory Services share in HRL)
Pty. Ltd. (ACN 009
936 029) by on-
market purchase
26 / 07 / 2022 ALS Limited (ACN 009Acquisition of fully $1,267,205.28 7,920,033 fully paid 7,920,033
657 489)paid ordinary shares (being $0.16 per ordinary shares in
in HRL by Australian fully paid ordinary HRL
Laboratory Services share in HRL)
Pty. Ltd. (ACN 009
936 029) by on-
market purchase

4. Present relevant interests

Particulars of each relevant interest of the substantial holder in voting securities after the change are as follows:

Holder of relevantinterest Registeredholder ofsecurities Registeredholder ofsecurities Person entitled to beregistered as holder (8) Person entitled to beregistered as holder (8) Nature of relevantinterest (6) Class and number ofsecurities Class and number ofsecurities Person’s votes
Australian LaboratoryServices Pty. Ltd. (ACN009 936 029) AustralianLaboratoryServices Pty. Ltd.(ACN 009 936029) Australian LaboratoryServices Pty. Ltd. (ACN009 936 029) Registered holderof securities -Section 608(1)(a)of the_Corporations_Act 2001(Cth) 425,884,273 fully paidordinary shares in HRL 425,884,273
425,884,273
ALS Limited (ACN 009657 489) AustralianLaboratoryServices Pty. Lt Australian LaboratoryServices Pty. Ltd. (ACN Relevant interest insecurities held by a 425,884,273 fully paidordinary shares in HRL
d. 009 936 029) body corporate in'
(ACN 009 936029) which the personsvoting power is
above 20% (ALS
Limited (ACN 009657 489) has voting
power above 20%in AustralianLaboratoryServices Pty. Ltd.(ACN 009 936029)) - Section608(3)(a) of theCorporations Act2001(Cth)

5. Changes in association

The persons who have become associates (2) of, ceased to be associates of, or have changed the nature of their association (9) with, the relation to voting interests in the company or scheme are as follows:

Name and ACN/ARSN (if applicable) Nature of association
N/A - no changes from the previous notice N/A - no changes from the previous notice
N/A - no changes from the previous notice N/A - no changes from the previous notice

6. Addresses

The addresses of persons named in this form are as follows:

Name Address
Australian Laboratory Services Pty. Ltd. (ACN 009 936 Level 2, 299 Coronation Drive, Milton, Queensland, 4064
029)
ALS Limited (ACN 009 657 489) Level 2, 299 Coronation Drive, Milton, Queensland, 4064

Signature

Michael Paul Pearson capacity Company secretary of
Australian Laboratory
Services Pty. Ltd. (ACN 009
936 029) and ALS Limited
(ACN 009 657 489)
date 27 / 07 / 2022

print name Michael Paul Pearson

sign here

DIRECTIONS

  • (1) If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 6 of the form.

  • (2) See the definition of "associate" in section 9 of the Corporations Act 2001.

  • (3) See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.

  • (4) The voting shares of a company constitute one class unless divided into separate classes.

  • (5) The person’s votes divided by the total votes in the body corporate or scheme multiplied by 100.

  • (6) Include details of:

(any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any adocument setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or )arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and

(any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to bwhich the relevant interest relates (indicating clearly the particular securities to which the qualification applies). )

See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.

  • (7) Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included on any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.

  • (8) If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write “unknown’”.

  • (9) Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice.